Tiffany Khong

1.4k citations
52 papers · 908 indexed · h-index 17
Topics
Multiple Myeloma Research and Treatments (42 papers)Protein Degradation and Inhibitors (18 papers)Peptidase Inhibition and Analysis (12 papers)

In The Last Decade

Tiffany Khong

49 papers receiving 903 citations

Peers

Tiffany Khong
Comparison fields: 5 of 71
  • Molecular Biology 678
  • Hematology 466
  • Oncology 275
  • Cancer Research 193
  • Genetics 97
Replace Lara Tickenbrock with:
Lara Tickenbrock Germany
Guilhem Requirand France
Maurizio Affer United States
Bryan Ciccarelli United States
Daisy Huynh United States
Victoria M. Garbitt United States
Ernesto Díaz-Flores United States
Paola Storti Italy
Kazumasa Aoyama Japan
Geneviève Fiol France
Tiffany Khong relative to Lara Tickenbrock Germany Lara Tickenbrock's profile →
Citations per field
00.5×1.5×2.5×
Lara Tickenbrock · 1×
Citations per year

Countries citing papers authored by Tiffany Khong

Since Specialization
Citations

This map shows the geographic impact of Tiffany Khong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffany Khong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffany Khong more than expected).

Fields of papers citing papers by Tiffany Khong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffany Khong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffany Khong. The network helps show where Tiffany Khong may publish in the future.

Co-authorship network of co-authors of Tiffany Khong

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffany Khong. A scholar is included among the top collaborators of Tiffany Khong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffany Khong. Tiffany Khong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 3
5 15
6 4
7 9
8 4
9 46
10 4
11 39
12 1
13 23
14 144
15 68
16 16
17 11
18 1
19 17
20 20

About Tiffany Khong

Tiffany Khong is a scholar working on Hematology, Oncology and Cancer Research, having authored 52 papers that have together received 908 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (42 papers), Protein Degradation and Inhibitors (18 papers) and Peptidase Inhibition and Analysis (12 papers). The work is most often cited by research in Hematology (466 citations), Cancer Research (193 citations) and Oncology (275 citations). Tiffany Khong has collaborated with scholars based in Australia, United States and South Korea. Frequent co-authors include Andrew Spencer, Sridurga Mithraprabhu, Anna Kalff, Annie Chow, Christopher J. Burns, Maoshan Chen, Adam Spencer, Antonia Reale, John Sharkey and Andrew W. Roberts. Their work appears in journals such as Blood, Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026